• CNTA

Centessa Pharmaceuticals CEO sells over $900k in company stock

Saurabh Saha, CEO of Centessa Pharmaceuticals, sold 55,000 shares under a planned trading scheme. The company shows promising drug trial results amidst scrutiny of financial performance.